Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron vs Dexmedetomidine for Postspinal Shivering in Cesarean Section
NCT06762860Enrolling by invitation
- Sponsor
- Minia University
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of granisetron and dexmedetomidine in postanesthetic shivering (PAS) (3 arms), sponsored by Minia University. Primary endpoint: The incidence and severity of post spinal shivering. Started Jan 2024; status: enrolling by invitation.
02
Drugs
granisetrondexmedetomidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT06762860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06762860.